Journal of Pharmaceutical and Biomedical Analysis, volume 51, issue 5, pages 1037-1046

Identification and characterization of degradation products of irbesartan using LC–MS/TOF, MSn, on-line H/D exchange and LC–NMR

Ravi P Shah 1
Archana Sahu 1
Saranjit Singh 1
1
 
Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar, 160062, Punjab, India.
Publication typeJournal Article
Publication date2010-04-01
Quartile SCImago
Q2
Quartile WOS
Q2
Impact factor3.4
ISSN07317085, 1873264X
Drug Discovery
Spectroscopy
Pharmaceutical Science
Clinical Biochemistry
Analytical Chemistry
Abstract
Irbesartan was subjected to hydrolytic, oxidative, photolytic and thermal stress, according to ICH guideline Q1A (R2). The drug showed degradation only in acidic, basic and photoacidic conditions, while it was stable to other stress conditions. A total of three degradation products were formed, which were separated on a C-8 column employing a gradient HPLC method. Initially, a complete mass fragmentation pathway of the drug was established with the help of MS/TOF, MS(n) and H/D exchange studies. Subsequently, the degradation products were subjected to LC-MS/TOF and on-line H/D exchange mass studies to obtain their accurate mass, fragment pattern and number of labile hydrogens. The MS results helped to assign tentative structures to degradation products, which were verified through (1)H and 2D COSY LC-NMR experiments. The products were identified as (2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methanamine, 1-(1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methylamino)pentylideneamino)cyclopentane carboxylic acid and 2-butyl-3-(tetrazolo[1,5-f]phenanthridin-6-ylmethyl)-1,3-diazaspiro[4.4]non-1-en-4-one. The structures were justified by mechanisms of their formation.

Top-30

Citations by journals

1
2
3
4
5
6
Journal of Pharmaceutical and Biomedical Analysis
6 publications, 12.24%
Journal of Chromatography A
2 publications, 4.08%
Journal of Pharmaceutical Sciences
2 publications, 4.08%
Journal of Hazardous Materials
2 publications, 4.08%
Science of the Total Environment
2 publications, 4.08%
TrAC - Trends in Analytical Chemistry
2 publications, 4.08%
Journal of Mass Spectrometry
2 publications, 4.08%
Current Pharmaceutical Analysis
1 publication, 2.04%
Main Group Chemistry
1 publication, 2.04%
Journal of Planar Chromatography - Modern TLC
1 publication, 2.04%
Bioanalysis
1 publication, 2.04%
European Journal of Mass Spectrometry
1 publication, 2.04%
Molecules
1 publication, 2.04%
Catalysts
1 publication, 2.04%
Analytical and Bioanalytical Chemistry
1 publication, 2.04%
Soil Biology and Biochemistry
1 publication, 2.04%
Chemical Engineering Journal Advances
1 publication, 2.04%
Heliyon
1 publication, 2.04%
Sustainable Chemistry and Pharmacy
1 publication, 2.04%
Journal of Analytical and Applied Pyrolysis
1 publication, 2.04%
Mass Spectrometry Reviews
1 publication, 2.04%
Crystal Growth and Design
1 publication, 2.04%
Organic Process Research and Development
1 publication, 2.04%
Analytical Methods
1 publication, 2.04%
RSC Advances
1 publication, 2.04%
New Journal of Chemistry
1 publication, 2.04%
European Journal of Chemistry
1 publication, 2.04%
Profiles of Drug Substances, Excipients and Related Methodology
1 publication, 2.04%
Asian Journal of Pharmaceutical Analysis
1 publication, 2.04%
1
2
3
4
5
6

Citations by publishers

5
10
15
20
25
Elsevier
22 publications, 44.9%
Wiley
6 publications, 12.24%
Multidisciplinary Digital Publishing Institute (MDPI)
3 publications, 6.12%
Royal Society of Chemistry (RSC)
3 publications, 6.12%
American Chemical Society (ACS)
2 publications, 4.08%
Bentham Science
1 publication, 2.04%
IOS Press
1 publication, 2.04%
Akademiai Kiado
1 publication, 2.04%
Future Medicine
1 publication, 2.04%
SAGE
1 publication, 2.04%
Springer Nature
1 publication, 2.04%
European Journal of Chemistry
1 publication, 2.04%
A and V Publications
1 publication, 2.04%
Oriental Scientific Publishing Company
1 publication, 2.04%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 2.04%
5
10
15
20
25
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Shah R. P., Sahu A., Singh S. Identification and characterization of degradation products of irbesartan using LC–MS/TOF, MSn, on-line H/D exchange and LC–NMR // Journal of Pharmaceutical and Biomedical Analysis. 2010. Vol. 51. No. 5. pp. 1037-1046.
GOST all authors (up to 50) Copy
Shah R. P., Sahu A., Singh S. Identification and characterization of degradation products of irbesartan using LC–MS/TOF, MSn, on-line H/D exchange and LC–NMR // Journal of Pharmaceutical and Biomedical Analysis. 2010. Vol. 51. No. 5. pp. 1037-1046.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.jpba.2009.11.008
UR - https://doi.org/10.1016/j.jpba.2009.11.008
TI - Identification and characterization of degradation products of irbesartan using LC–MS/TOF, MSn, on-line H/D exchange and LC–NMR
T2 - Journal of Pharmaceutical and Biomedical Analysis
AU - Shah, Ravi P
AU - Sahu, Archana
AU - Singh, Saranjit
PY - 2010
DA - 2010/04/01 00:00:00
PB - Elsevier
SP - 1037-1046
IS - 5
VL - 51
SN - 0731-7085
SN - 1873-264X
ER -
BibTex |
Cite this
BibTex Copy
@article{2010_Shah,
author = {Ravi P Shah and Archana Sahu and Saranjit Singh},
title = {Identification and characterization of degradation products of irbesartan using LC–MS/TOF, MSn, on-line H/D exchange and LC–NMR},
journal = {Journal of Pharmaceutical and Biomedical Analysis},
year = {2010},
volume = {51},
publisher = {Elsevier},
month = {apr},
url = {https://doi.org/10.1016/j.jpba.2009.11.008},
number = {5},
pages = {1037--1046},
doi = {10.1016/j.jpba.2009.11.008}
}
MLA
Cite this
MLA Copy
Shah, Ravi P., et al. “Identification and characterization of degradation products of irbesartan using LC–MS/TOF, MSn, on-line H/D exchange and LC–NMR.” Journal of Pharmaceutical and Biomedical Analysis, vol. 51, no. 5, Apr. 2010, pp. 1037-1046. https://doi.org/10.1016/j.jpba.2009.11.008.
Found error?